BERKELEY, Calif., June 24, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (Nasdaq: PFSA), a digital health company pioneering next-generation biosensing technologies, announces...
– Orders reinforce strong demand outlook in global health markets and supports 2026 revenue and profitability targets – Company publishes...
BERKELEY, CA, June 12, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (Nasdaq: PFSA), a digital health company pioneering next-generation biosensing technologies,...
BERKELEY, CA, June 10, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a leading digital health...
Company focusing resources on near-term commercial milestones; European CE Mark process and Healthcare Research revenue opportunities Process intended to evaluate...
Collaboration Demonstrates Sequenex’s Commitment to Innovation in Medical TechnologyLOS ANGELES & ATLANTA--(BUSINESS WIRE)--Sequenex today announced its partnership with MedTech Innovator...
Developed by Albert Einstein College of Medicine and the Salk Institute for Biological Studies, Multicolor Imaging Technology Lets Researchers Track...
NEW YORK, April 21, 2026 /PRNewswire/ -- UltraGreen Cardiac Technologies, a business unit of UltraGreen.ai ("UltraGreen" or the "Company"), a global...
NEW YORK, April 21, 2026 /PRNewswire/ -- UltraGreen Cardiac Technologies, a business unit of UltraGreen.ai ("UltraGreen" or the "Company"), a global...
NEW YORK, April 21, 2026 /PRNewswire/ -- UltraGreen Cardiac Technologies, a business unit of UltraGreen.ai ("UltraGreen" or the "Company"), a global...
Surge in AI & IoT-enabled smart wearables, rising healthcare monitoring demand, and expanding enterprise deployments are reshaping the global wearable...
Recognized at the American College of Cardiology Scientific Sessions for advancing cuffless blood pressure measurementOKLAHOMA CITY, April 1, 2026 /PRNewswire/...
One of four companies selected to present at the American College of Cardiology Scientific Sessions in New OrleansOKLAHOMA CITY, March...
New research introduces Sprints — the first program to combine generative AI with continuous wearable biometrics to optimize metabolic health...
DUBLIN and NEW YORK, March 18, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused...
Company begins roll out of innovative diabetes care HbA1c column system in Brazil Commercial leadership strengthened with key appointment DUBLIN, March...
- Clinical trial results support progression of CGM+ toward regulatory submissions and scaled commercialization - Anticipating initiation of pivotal clinical...
DUBLIN, March 10, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics...
The femtech market growth is driven by the increasing awareness of women's health issues, rising prevalence of reproductive and hormonal...
CAMBRIDGE, Mass., March 3, 2026 /PRNewswire/ -- Draper has joined a multidisciplinary team of experts from industry, academia, and public...